TY - JOUR
T1 - Sellar metastasis from clear cell sarcoma: Description of the first case
AU - Doglietto, Francesco
AU - Daffini, Linda
AU - Fazzari, Elena
AU - Cominelli, Manuela
AU - Pagani, Francesca
AU - Poliani, Pietro Luigi
PY - 2022
Y1 - 2022
N2 - Metastases to the sellar region and pituitary gland are rare and usually occur in advanced cancers, commonly breast and lung adenocarcinomas. Metastases from sarcomas to the pituitary gland are extremely rare. Here, we report the case of a 52-year-old man who had undergone surgery and radiotherapy for a clear cell sarcoma (CCS) of the knee at age of 42. The patient underwent resection of 2 distinct metastatic lung nodules 9 years later. During follow-up, he developed a persistent headache and diabetes insipidus. MRI revealed a sellar and suprasellar lesion, which was removed with an endoscopic trans-sphenoidal approach. Histopathology was consistent with CSS metastasis. At 2-year follow-up, there was no evidence of local recurrence in the sella, while a single brain metastasis was documented, together with other deposits in the paravertebral and pelvic muscles. CCS is a rare, aggressive neoplasm usually involving the deep soft tissue of the extremities, including trunk or limb girdles, and extensive surgical removal, along with adjuvant chemo- and radiotherapy, significantly prolongs survival. Nevertheless, prognosis remains poor, mainly due to frequent local recurrences and eventually distant metastases, usually within regional lymph nodes, lung, and bone. To the best of our knowledge, this is the first description of a sellar metastasis from CCS.
AB - Metastases to the sellar region and pituitary gland are rare and usually occur in advanced cancers, commonly breast and lung adenocarcinomas. Metastases from sarcomas to the pituitary gland are extremely rare. Here, we report the case of a 52-year-old man who had undergone surgery and radiotherapy for a clear cell sarcoma (CCS) of the knee at age of 42. The patient underwent resection of 2 distinct metastatic lung nodules 9 years later. During follow-up, he developed a persistent headache and diabetes insipidus. MRI revealed a sellar and suprasellar lesion, which was removed with an endoscopic trans-sphenoidal approach. Histopathology was consistent with CSS metastasis. At 2-year follow-up, there was no evidence of local recurrence in the sella, while a single brain metastasis was documented, together with other deposits in the paravertebral and pelvic muscles. CCS is a rare, aggressive neoplasm usually involving the deep soft tissue of the extremities, including trunk or limb girdles, and extensive surgical removal, along with adjuvant chemo- and radiotherapy, significantly prolongs survival. Nevertheless, prognosis remains poor, mainly due to frequent local recurrences and eventually distant metastases, usually within regional lymph nodes, lung, and bone. To the best of our knowledge, this is the first description of a sellar metastasis from CCS.
KW - Humans
KW - Male
KW - Middle Aged
KW - Prognosis
KW - Sarcoma, Clear Cell
KW - Soft Tissue Neoplasms
KW - clear cell sarcoma
KW - pituitary metastasis
KW - sellar metastasis
KW - sellar region tumors
KW - sellar sarcoma
KW - trans-sphenoidal surgery
KW - Humans
KW - Male
KW - Middle Aged
KW - Prognosis
KW - Sarcoma, Clear Cell
KW - Soft Tissue Neoplasms
KW - clear cell sarcoma
KW - pituitary metastasis
KW - sellar metastasis
KW - sellar region tumors
KW - sellar sarcoma
KW - trans-sphenoidal surgery
UR - http://hdl.handle.net/10807/209506
U2 - 10.5414/NP301448
DO - 10.5414/NP301448
M3 - Article
SN - 0722-5091
VL - 41
SP - 122
EP - 127
JO - Clinical Neuropathology
JF - Clinical Neuropathology
ER -